Simeone, Christopher A.
Wilkerson, Joseph L. http://orcid.org/0000-0003-4683-7589
Poss, Annelise M.
Banks, James A.
Varre, Joseph V.
Guevara, Jose Lazaro http://orcid.org/0000-0003-0741-4225
Hernandez, Edgar Javier http://orcid.org/0000-0003-1455-8251
Gorsi, Bushra
Atkinson, Donald L.
Turapov, Tursun http://orcid.org/0000-0002-7375-5565
Frodsham, Scott G.
Morales, Julio C. Fierro
O’Neil, Kristina
Moore, Barry
Yandell, Mark http://orcid.org/0000-0002-9497-4505
Summers, Scott A. http://orcid.org/0000-0002-4919-0592
Krolewski, Andrzej S. http://orcid.org/0000-0002-1705-2953
Holland, William L. http://orcid.org/0000-0001-9950-1435
Pezzolesi, Marcus G. http://orcid.org/0000-0002-4093-3783
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK128641, 5T32DK091317, 5T32DK091317, DK116888, DK116450, DK47475, DK58549, DK108833, DK112826)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
Article History
Received: 11 November 2021
Accepted: 6 July 2022
First Online: 22 July 2022
Competing interests
: S.A.S. is a consultant, cofounder, and shareholder of Centaurus Therapeutics. The other authors declare no competing financial or nonfinancial interests.